Literature DB >> 16849552

Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms.

Yuan Rong1, Fang Hu, Ruopan Huang, Nigel Mackman, Jonathan M Horowitz, Randy L Jensen, Donald L Durden, Erwin G Van Meir, Daniel J Brat.   

Abstract

Hypoxia strongly up-regulates tissue factor and promotes plasma clotting by glioblastoma multiforme, but transcriptional mechanisms remain undefined. Here, we investigated the potential roles of early growth response gene-1 (Egr-1), Sp1, nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1), and hypoxia-inducible factor-1 (HIF-1) in the hypoxic regulation of tissue factor by glioblastoma multiforme cells in vitro. Hypoxia (1% O2) strongly induced Egr-1 mRNA within 1 hour and led to nuclear localization of Egr-1 protein. Using luciferase reporter plasmids in glioma cells, we found that hypoxia dramatically increased luciferase activity in cells with constructs containing Egr-1-binding sites but not in cells with constructs containing AP-1- or NF-kappaB-binding sites. Electrophoretic mobility shift assays revealed hypoxia-induced Egr-1, but not Sp1, binding to oligonucleotides containing the Egr-1/Sp1 motif of tissue factor gene promoter. Using an expression vector containing the minimal tissue factor promoter (-111 to +14 bp) and small interfering RNA (siRNA) directed at Egr-1 and Sp1 mRNAs, we found that Egr-1 was required for maximal hypoxic induction of promoter activity. Forced overexpression of Egr-1 but not Sp1 by cDNA transfection caused up-regulation of tissue factor in glioma cells under normoxia (21% O2), whereas siRNA directed at Egr-1 strongly attenuated hypoxia-induced tissue factor expression. To examine the effects of HIF-1alpha on tissue factor expression, we used glioma cells stably transfected with a HIF-1alpha siRNA expression vector and found that HIF-1alpha mRNA silencing did not affect tissue factor expression under hypoxia. We conclude that hypoxic up-regulation of tissue factor in glioblastoma multiforme cells depends largely on Egr-1 and is independent of HIF-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849552      PMCID: PMC2610484          DOI: 10.1158/0008-5472.CAN-06-0346

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods.

Authors:  T D Schmittgen; B A Zakrajsek; A G Mills; V Gorn; M J Singer; M W Reed
Journal:  Anal Biochem       Date:  2000-10-15       Impact factor: 3.365

Review 2.  The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review.

Authors:  L C Marras; W H Geerts; J R Perry
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

3.  Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.

Authors:  G Krikun; F Schatz; N Mackman; S Guller; R Demopoulos; C J Lockwood
Journal:  Mol Endocrinol       Date:  2000-03

Review 4.  Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.

Authors:  D J Brat; E G Van Meir
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 5.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

6.  PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.

Authors:  Yuan Rong; Dawn E Post; Russell O Pieper; Donald L Durden; Erwin G Van Meir; Daniel J Brat
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

7.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

8.  Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration.

Authors:  S F Yan; J Lu; L Xu; Y S Zou; J Tongers; W Kisiel; N Mackman; D J Pinsky; D M Stern
Journal:  J Appl Physiol (1985)       Date:  2000-06

9.  Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells.

Authors:  K Kaufmann; G Thiel
Journal:  J Neurol Sci       Date:  2001-08-15       Impact factor: 3.181

Review 10.  Gene targeting in hemostasis. tissue factor.

Authors:  N Mackman
Journal:  Front Biosci       Date:  2001-02-01
View more
  36 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.

Authors:  Lee A D Cooper; David A Gutman; Candace Chisolm; Christina Appin; Jun Kong; Yuan Rong; Tahsin Kurc; Erwin G Van Meir; Joel H Saltz; Carlos S Moreno; Daniel J Brat
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

3.  Placenta growth factor-induced early growth response 1 (Egr-1) regulates hypoxia-inducible factor-1alpha (HIF-1alpha) in endothelial cells.

Authors:  Nitin Patel; Vijay K Kalra
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

4.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Thromboembolic disease in patients with high-grade glioma.

Authors:  James R Perry
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

6.  ELTD1, a potential new biomarker for gliomas.

Authors:  Rheal A Towner; Randy L Jensen; Howard Colman; Brian Vaillant; Nataliya Smith; Rebba Casteel; Debra Saunders; David L Gillespie; Robert Silasi-Mansat; Florea Lupu; Cory B Giles; Jonathan D Wren
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

Review 7.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 8.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.

Authors:  N Yokota; S Koizume; E Miyagi; F Hirahara; Y Nakamura; K Kikuchi; W Ruf; Y Sakuma; E Tsuchiya; Y Miyagi
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

10.  Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  Siddhesh Aras; Gyanendra Singh; Kenneth Johnston; Timothy Foster; Ashok Aiyar
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.